  |
Equity Research Analysts
Robert M. Wasserman Mr. Wasserman has over seventeen years experience in equity research, specializing in the areas of health care with a unique focus on companies in the Southeastern US and Florida. Among the areas Mr. Wasserman has covered are pharmaceuticals, medical devices, healthcare services and biotechnology. Mr. Wasserman has analyzed and written on over 100 publicly traded health care companies. Prior to joining Jesup & Lamont, Mr. Wasserman was Director of Research at Skye Capital, and Senior Research Analyst for Craig-Hallum Capital Group and Vice President - Research and Partner for Southeast Research Partners/Ryan Beck. Prior to entering the securities industry, Mr. Wasserman was a management consultant with Peat, Marwick, Mitchell & Co., now KPMG Peat Marwick. Mr. Wasserman was selected All-Star Healthcare analyst for 2000 by the Wall Street Journal, and has appeared in number of media outlets, including Business Week, Forbes, The New York Times and CNBC. Mr. Wasserman received his Masters of Business Administration degree in Finance from the University of Chicago and dual Bachelor of Science degrees in Management and Engineering from the Massachusetts Institute of Technology.
|
Jesup & Lamont is a member of FINRA (www.finra.org), SIPC, & MSRB SIPC provides protection of up to $500,000, including a maximum of $100,000 for cash balances. Excess SIPC Surety Bond No. 1016-04 provides each Customer of First Clearing, LLC Customer by Asset Protection Company (“CAPCOâ€) with replacement or payment coverage up to that portion of the Customer’s Net Equity that represents a loss of Securities (as defined in SIPA) and/or cash that is in excess over all receipts by the Customer with respect to the Customer’s Net Equity. SIPC does not guarantee the future value of any security. For full details, see http://www.sipc.org
Senior Analyst